ergoline and Neurofibromatosis-1

ergoline has been researched along with Neurofibromatosis-1* in 2 studies

Other Studies

2 other study(ies) available for ergoline and Neurofibromatosis-1

ArticleYear
Large pituitary gland with an expanding lesion in the context of neurofibromatosis 1.
    BMJ case reports, 2017, Oct-25, Volume: 2017

    Topics: Acromegaly; Adult; Antineoplastic Agents; Cabergoline; Central Nervous System Cysts; Ergolines; Female; Human Growth Hormone; Humans; Magnetic Resonance Imaging; Neurofibromatosis 1; Pituitary Gland; Pituitary Neoplasms

2017
A double pituitary adenoma presenting as a prolactin-secreting tumor with partial response to medical therapy. Case report.
    Endocrine pathology, 2010, Volume: 21, Issue:2

    Double pituitary adenomas are difficult to recognize pre-operatively as only a single mass may be appreciated on imaging. We present herein a giant prolactin-secreting pituitary adenoma in a middle-aged man that had responded partially to dopamine agonist therapy. The excised specimen demonstrated a double adenoma. The prolactin-producing one displayed the expected morphological changes resulting from medical therapy, while the other, a gonadotroph adenoma, did not. The failure of tumor shrinkage can be attributed to the presence of a double adenoma, a previously unreported cause of failure of medical therapy in prolactinoma.

    Topics: Adenoma; Adult; Antineoplastic Agents; Breast Neoplasms, Male; Cabergoline; Combined Modality Therapy; Ergolines; Gonadotrophs; Humans; Male; Microscopy, Electron, Transmission; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neurofibromatosis 1; Neurosurgical Procedures; Prolactinoma

2010